| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $304.1M | +4.3% |
| R&D Expense | $51.0M | +4.3% |
| SG&A Expense | $49.4M | +4.7% |
| Operating Income | $20.2M | -4.9% |
| Pre-tax Income | $23.2M | -6.4% |
| Income Tax | $4.9M | +1.7% |
| Net Income | $18.3M | -8.3% |
| EPS (Basic) | $0.61 | -7.6% |
| EPS (Diluted) | $0.61 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.2M | -39.2% |
| Accounts Receivable | $32.2M | +6.5% |
| Current Assets | $119.7M | -21.9% |
| Total Assets | $520.4M | +1.9% |
| Current Liabilities | $124.1M | +7.3% |
| Stockholders' Equity | $354.0M | -1.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.3M | +9.8% |
| Capital Expenditures | $3.7M | +163.0% |
| Investing Cash Flow | -$50.4M | -48.2% |
| Financing Cash Flow | -$36.3M | -703.1% |
| Free Cash Flow | $59.6M | +6.0% |
| -7.6% |